Patents by Inventor Henry I. Huang

Henry I. Huang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-HIV protein, TAP 29, from tricosanthes, DNA coding therefor and therapeutic uses thereof
    Patent number: 5532214
    Abstract: A new protein, termed TAP 29, obtainable from the root tuber of the plant Trichosanthes kirilowii or produced by recombinant means is useful for treating HIV infections or tumors. In treating HIV infections, the protein is administered alone or in conjunction with conventional AIDS therapies. Also provided are processes for purifying the protein, DNA sequences encoding the protein, hosts expressing the protein, recombinant DNA methods for expressing the protein, and antibodies specific for the protein.
    Type: Grant
    Filed: July 14, 1994
    Date of Patent: July 2, 1996
    Assignees: New York University, American Biosciences, Inc., The United States of America as represented by the Department of Health and Human Services
    Inventors: Sylvia Lee-Huang, Philip L. Huang, Hao-chia Chen, Hsiang-fu Kung, Peter Huang, Henry I. Huang, Paul L. Huang
  • Plant protein useful for treating tumors and HIV infection
    Patent number: 5484889
    Abstract: A protein, in particular MAP 30, obtainable from both the fruit and seeds of Momordica charantia or produced by recombinant means useful for treating tumors and HIV infections is disclosed. In treating HIV infections, the protein is administered alone or in conjunction with conventional AIDS therapies. Also provided are processes for purifying the protein, DNA sequences encoding the protein, and recombinant DNA methods for expressing the protein.
    Type: Grant
    Filed: July 21, 1994
    Date of Patent: January 16, 1996
    Assignees: New York University, American Biosciences, Inc., The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: Sylvia Lee-Huang, Philip L. Huang, Peter L. Nara, Hao-Chia Chen, Hsiang-fu Kung, Peter Huang, Henry I. Huang, Paul L. Huang
  • Anti-HIV proteins GAP 31, DAP 30 and DAP 32 and therapeutic uses thereof
    Patent number: 5317009
    Abstract: New proteins, termed GAP 31, obtainable from the seeds of Gelonium multiflorum, and DAP 30 and DAP 32, obtainable from the leaves or seeds of Dianthus caryophyllus, or the above proteins produced by recombinant means, are useful for treating HIV infections. In treating HIV infections, the protein is administered alone or in conjunction with other anti-HIV therapeutics. Also provided are processes for purifying the proteins, DNA sequences encoding the proteins, hosts expressing the proteins, recombinant DNA methods for expressing the proteins, and antibodies specific for the proteins.
    Type: Grant
    Filed: August 26, 1991
    Date of Patent: May 31, 1994
    Assignees: New York University, American Biosciences, Inc., National Institutes of Health
    Inventors: Sylvia Lee-Huang, Hsiang-fu Kung, Paul L. Huang, Philip L. Huang, Peter Huang, Henry I. Huang, Hao-chia Chen